Summary
35 / 100 · Bulios Score
What speaks for it
- It has been profitable 6 years in a row.
- It passes 8 of the 9 points of the Piotroski financial health test.
What to watch
- Repaying its net debt would take 5.2 years of operating profit.
- Revenue fell by 5.8% a year over the last 3 years.
- It cut its dividend by 21% last year.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 23.5 THB for 1 THB of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (THB)
Diluted EPS (THB)
- Analyst estimate
Revenue grew by 3.6% a year over 5 years. Over the last 3 years it fell by 5.8% a year. Earnings per share fell by 14% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 THB of revenue goes
- Cost of sales 84 THB
- Sales and administration 13 THB
- Taxes and other -0.0 THB
- Net profit 3.3 THB
Net profit, industry median (Conglomerates) 6.2 THB
Out of every 100 THB of revenue, 3.3 THB is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 10.8 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.95%
- Paid out of profit
- 46%
You receive $0.16 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.